Darshan Singh

Darshan Singh

Author is a pharmaceutical quality and regulatory professional with more than 23 years in drug manufacturing. He holds an M.Sc. in Organic Chemistry and a Diploma in Pharmacy. He has served as Quality Control Head, Quality Assurance Head and Plant Head, overseeing all manufacturing operations. He is co-founder and regulatory consultant at Laafon Galaxy Pharmaceuticals. He writes on SOPs, manufacturing processes, Schedule M compliance and drug pharmacology, and checks each claim against pharmacopoeial and regulatory sources.

NPPA revised the ceiling price of 11 formulations!

The government set up a department called the National Pharmaceutical Pricing Authority (NPPA) to control the prices of medicines in India. This department is tasked with making sure medicine is affordable but also available to everyone. Therefore, NPPA revised the…

156 FDCs ban drugs list 2024

156 FDCs ban drugs list 2024

In a surprise order vide gazzete notification, the Health and Family Welfare Ministry, Government of India issued a 156 FDCs ban drugs list 2024. , The matter was examined by an Expert Committee appointed by the Central Government and the…

Latest DPCO list 2024 after WPI impact

latest dpco list 2024

In the month of March 2024, NPPA the supreme body responsible for fixing the ceiling price of medicines in India announced an increase of 0.00551% increase in the existing prices of medicines that are covered under DPCO Order 2013. In…